台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    114.0
  • 漲跌
    ▼3.0
  • 漲幅
    -2.56%
  • 成交量
    337
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智基 (6294)籌碼相關-元大-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/05/0500.003109.50109.00-353-5.66%
2023/04/1800.002109.50109.00-252-3.83%
2023/04/130119.0000.00119.500470.03%
2023/04/100121.0000.00120.500390.00%
2023/02/011107.0000.00107.501392.56%
2023/01/0300.000108.00107.00039-0.10%
2022/12/062101.0000.00102.002345.87%
2022/12/022100.0000.00100.502306.61%
2022/11/04099.9000.0099.200190.10%
2022/10/140104.5000.00105.000140.13%
2021/09/0100.001147.00147.00-135-2.83%
2021/08/041140.5000.00144.001362.72%
2021/08/0300.001155.00156.00-135-2.80%
2021/02/221125.5000.00125.501263.72%
2021/01/1800.000.3123.00123.50-0.335-0.75%
2021/01/140123.5000.00124.000340.04%
2021/01/040124.5000.00125.000320.07%
2020/12/250122.5000.00122.000350.09%
2020/12/230123.0000.00122.500350.04%
2020/12/220.1123.5000.00122.500.1350.28%
2020/12/180122.0000.00122.500360.07%
2020/12/160122.0000.00124.000350.11%
2020/12/1400.000.1124.50123.50-0.134-0.43%
2020/12/110126.0000.00124.500340.04%
2020/11/300121.0000.00121.500310.08%
2020/11/190.1120.7500.00120.000.1340.24%
2020/08/240108.0000.00108.500570.07%
2020/03/1300.00494.4095.10-433-12.07%
2019/03/211111.500.2111.00111.500.8302.66%
2019/02/261110.5000.00109.001244.10%
2019/02/1900.001108.00108.50-122-4.51%
2019/02/1500.000.5108.50108.00-0.521-2.28%
2019/02/1400.002108.00108.50-221-9.32%
2019/02/111106.5000.00106.501214.56%
2018/11/1300.002104.25103.00-229-6.79%
2018/11/1200.001103.00104.00-129-3.39%
2018/11/051105.5000.00106.001303.30%
2018/11/011102.0000.00102.001293.42%
2018/07/3100.002113.50113.50-273-2.70%
2018/06/0700.003126.00126.50-3122-2.45%
2018/06/012124.0000.00124.0021211.65%
2018/05/252123.2500.00123.0021241.60%
2018/05/211124.0000.00124.5011270.78%
2018/05/153126.5000.00126.0031282.33%
2018/05/092128.7500.00129.0021271.57%
2018/03/2900.002128.00128.50-2161-1.24%
2018/03/272129.5000.00129.0021631.22%
2018/03/0200.007119.57120.00-7175-3.99%
2018/03/0100.002118.25118.00-2172-1.16%
2018/02/2700.007117.86117.00-7172-4.07%
2018/02/2600.007120.00116.50-7172-4.06%
2018/02/2300.009118.22117.00-9169-5.30%
2018/02/2200.001117.50115.50-1168-0.59%
2018/02/121113.5000.00113.5011670.60%
2018/02/062117.0000.00112.0021651.21%
2018/02/0200.004122.75123.00-4163-2.44%
2018/02/0100.001122.00120.00-1163-0.61%
2018/01/2500.005125.60123.50-5161-3.10%
2018/01/2400.006124.42124.00-6158-3.78%
2018/01/2300.002125.25123.00-2155-1.29%
2018/01/191126.001125.00124.0001480.00%
2018/01/1800.002123.75121.50-2134-1.49%
2018/01/1700.0013120.04121.50-13129-10.03%
2018/01/1500.0018115.75118.00-18114-15.67%
2018/01/0400.003112.50112.00-398-3.06%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音